Device Week, 12 Feb. 2020 – A Close-Up On AbioMed’s Plan to Counter Unfavorable Impella Data.

Citeline Podcasts

English - February 12, 2020 21:57 - 5 minutes - 10.6 MB - ★★★★★ - 24 ratings
Business News Business News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Device Week, 7 February 2020 – UK's Brexit From EU Creates Medtech Uncertainties

Next Episode: Device Week, 20 February 2020 – Industry Concerns Grow As Clock Running Out On EU MDR

In this edition of Device Week, Medtech Insight's managing editor Marion Webb talks with deputy editor Reed Miller about his recent story on Abiomed's plan to counter unfavorable study outcomes of its Impella heart pump.

Medtech Insight articles addressing topics discussed in this episode:

AbioMed Launches Plan To Counter Unfavorable Impella Data
https://medtech.pharmaintelligence.informa.com/MT126227/Abiomed-Launches-$100M-Plan-To-Counter-Unfavorable-Impella-Data

Start-Up Spotlight: BioIntelliSense Launches New FDA-Cleared BioSticker For Remote Monitoring Of Patients' Vital Signs
https://medtech.pharmaintelligence.informa.com/MT126231/StartUp-Spotlight-BioIntelliSense-Launches-New-FDACleared-BioSticker-For-Remote-Monitoring-Of-Patien

Knees Boost Zimmer Biomet; Turnaround Continues, But FDA Woes Linger
https://medtech.pharmaintelligence.informa.com/MT126216/Knees-Boost-Zimmer-Biomet-Turnaround-Continues-But-FDA-Woes-Linger

Boston Scientific Expects Up to $40M Impact In Q1 From Coronavirus Outbreak; 10%-12% Revenue Increase For 2020
https://medtech.pharmaintelligence.informa.com/MT126214/Boston-Scientific-Expects-Up-To-40M-Impact-In-Q1-From-Coronavirus-Outbreak-1012-Revenue-Increase-For

For more information on Medtech Insight and to start a free trial, click here:
http://bit.ly/2w7LnlR